Capo, V., Castiello, M. C., Fontana, E., Penna, S., Bosticardo, M., Draghici, E., . . . Villa, A. (2017). Efficacy of lentivirus-mediated gene therapy in an Omenn syndrome recombination-activating gene 2 mouse model is not hindered by inflammation and immune dysregulation. J Allergy Clin Immunol.
استشهاد بنمط شيكاغوCapo, Valentina, et al. "Efficacy of Lentivirus-mediated Gene Therapy in an Omenn Syndrome Recombination-activating Gene 2 Mouse Model Is Not Hindered By Inflammation and Immune Dysregulation." J Allergy Clin Immunol 2017.
MLA استشهادCapo, Valentina, et al. "Efficacy of Lentivirus-mediated Gene Therapy in an Omenn Syndrome Recombination-activating Gene 2 Mouse Model Is Not Hindered By Inflammation and Immune Dysregulation." J Allergy Clin Immunol 2017.